SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Secret_Agent_Man who started this subject12/21/2001 5:26:32 PM
From: IRWIN JAMES FRANKEL   of 508
 
Friday December 21, 5:21 pm Eastern Time
After The Bell - Tech shares steady in pre-holiday trade
NEW YORK, Dec 21 (Reuters) -
In another shelf registration, InterMune, Inc. (NasdaqNM:ITMN - news), a biotechnology company, said it has filed with the U.S. Securities and Exchange Administration to sell up to $150 million of stock, but has no immediate plans to offer the stock. InterMune's stock dipped to $50.10 in after hours trading, from a $50.30 regular close.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News